BioRestorative Therapies (BRTX) Gross Profit (2016 - 2025)
Historic Gross Profit for BioRestorative Therapies (BRTX) over the last 9 years, with Q3 2025 value amounting to $1230.0.
- BioRestorative Therapies' Gross Profit fell 9942.89% to $1230.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $357853.0, marking a year-over-year increase of 158.57%. This contributed to the annual value of $372928.0 for FY2024, which is 15578.05% up from last year.
- Per BioRestorative Therapies' latest filing, its Gross Profit stood at $1230.0 for Q3 2025, which was down 9942.89% from $294571.0 recorded in Q2 2025.
- BioRestorative Therapies' Gross Profit's 5-year high stood at $294571.0 during Q2 2025, with a 5-year trough of $1230.0 in Q3 2025.
- In the last 3 years, BioRestorative Therapies' Gross Profit had a median value of $37480.5 in 2024 and averaged $80532.0.
- Per our database at Business Quant, BioRestorative Therapies' Gross Profit soared by 60148.86% in 2024 and then plummeted by 9942.89% in 2025.
- Over the past 3 years, BioRestorative Therapies' Gross Profit (Quarter) stood at $19300.0 in 2023, then skyrocketed by 107.05% to $39961.0 in 2024, then crashed by 96.92% to $1230.0 in 2025.
- Its Gross Profit stands at $1230.0 for Q3 2025, versus $294571.0 for Q2 2025 and $22091.0 for Q1 2025.